Comparative study of on-demand and daily use of sertraline in treatment of premature ejaculation: A randomized clinical trial
- PMID: 33996478
- PMCID: PMC8099698
- DOI: 10.1016/j.ajur.2019.10.002
Comparative study of on-demand and daily use of sertraline in treatment of premature ejaculation: A randomized clinical trial
Abstract
Objective: The intravaginal ejaculatory latency time (IELT) may increase less in on-demand compared to daily intake, but may fulfill a suitable treatment for specific patients. We decided to compare the efficacy and safety of on-demand and daily use of sertraline in order to find the most effective and least complicated method in treatment of premature ejaculation (PE).
Methods: This study was parallel or concurrent control randomized clinical trial. Two hundred and forty patients with PE diagnosed by urologist in the two groups of 120 from July 2017 to February 2019 enrolled in the study. In the first group, it is prescribed 50 mg sertraline each 12 h daily and the second group received 50 mg 4 h before coitus for 4 and 8 weeks. The IELT before treatment and during all coitus after treatment were recorded by the patient's wife with a stopwatch.
Results: Mean IELT before, 4 and 8 weeks after treatment in two groups were: On-demand group 101.62±65.44 s, 208.75±128.02 s and 265.87±145.70 s; daily use group 102.50±81.22 s, 276.87±181.08 s and 353.75±176.45 s, respectively. The ejaculation time increased significantly in both groups (p<0.05). However, increase in ejaculation time in daily use group was significantly higher than the on-demand group in 4 weeks (p=0.036), especially in 8 weeks (p=0.009). The percent of side effects in daily use group (26.7%) was higher than on-demand group (20%) (p<0.05). Drowsiness, diarrhea and vertigo were significantly higher in the daily use than on-demand (p<0.05).
Conclusions: On-demand and daily use of sertraline are effective and usually have no serious complications, but the on-demand method is considerably more tolerable. In patients who did not tolerate to daily use of this drug, on-demand could be used as a salvage therapy.
Keywords: Intravaginal ejaculation latency time; On-demand; Premature ejaculation; Sertraline.
© 2021 Editorial Office of Asian Journal of Urology. Production and hosting by Elsevier B.V.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Which of available selective serotonin reuptake inhibitors (SSRIs) is more effective in treatment of premature ejaculation? A randomized clinical trial.Int Braz J Urol. 2019 Nov-Dec;45(6):1209-1215. doi: 10.1590/S1677-5538.IBJU.2019.0121. Int Braz J Urol. 2019. PMID: 31808410 Free PMC article. Clinical Trial.
-
Comparison of the safety and efficacy of the on-demand use of sertraline, dapoxetine, and daily use of sertraline in the treatment of patients with lifelong premature ejaculation: A prospective randomised study.Andrologia. 2020 Dec;52(11):e13854. doi: 10.1111/and.13854. Epub 2020 Oct 28. Andrologia. 2020. PMID: 33113277 Clinical Trial.
-
The Oxytocin Antagonist Cligosiban Prolongs Intravaginal Ejaculatory Latency and Improves Patient-Reported Outcomes in Men with Lifelong Premature Ejaculation: Results of a Randomized, Double-Blind, Placebo-Controlled Proof-of-Concept Trial (PEPIX).J Sex Med. 2019 Aug;16(8):1178-1187. doi: 10.1016/j.jsxm.2019.05.016. J Sex Med. 2019. PMID: 31351659 Clinical Trial.
-
[Intravaginal ejaculatory latency time: Advances in studies].Zhonghua Nan Ke Xue. 2016 Feb;22(2):165-70. Zhonghua Nan Ke Xue. 2016. PMID: 26939403 Review. Chinese.
-
An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second international society for sexual medicine ad hoc committee for the definition of premature ejaculation.Sex Med. 2014 Jun;2(2):41-59. doi: 10.1002/sm2.27. Sex Med. 2014. PMID: 25356301 Free PMC article. Review.
Cited by
-
Clinical value of penile sympathetic skin response to assess the efficacy of sertraline in the treatment of patients with sympathetic hyperexcitability in primary premature ejaculation.Sex Med. 2023 Jan 20;11(1):qfac012. doi: 10.1093/sexmed/qfac012. eCollection 2023 Feb. Sex Med. 2023. PMID: 37007857 Free PMC article.
References
-
- Symonds T., Roblin D., Hart K., Althof S. How does premature ejaculation impact a man s life? J Sex Marital Ther. 2003;29:361–370. - PubMed
-
- Serefoglu E.C., McMahon C.G., Waldinger M.D., Althof S.E., Shindel A., Adaikan G. An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second international society for sexual medicine ad hoc committee for the definition of premature ejaculation. J Sex Med. 2014;11:1423–1441. - PubMed
-
- McMahon C.G., Porst H. Oral agents for the treatment of premature ejaculation: review of efficacy and safety in the context of the recent International Society for Sexual Medicine criteria for lifelong premature ejaculation. J Sex Med. 2011;8:2707–2725. - PubMed
-
- Zargooshi J. Premature ejaculation: bother and intravaginal ejaculatory latency time in Iran. J Sex Med. 2009;6:3478–3489. - PubMed
-
- Waldinger M.D. Emerging drugs for premature ejaculation. Expert Opin Emerg Drugs. 2006;11:99–109. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources